BRAIN Biotech AG
Erik de Vries is an accomplished professional in the field of biotechnology, currently serving as the Senior Business Development Director for Enzymes at BRAIN Biotech AG since June 2024. Concurrently, Erik de Vries has been the Chief Executive Officer of Enzymicals AG since November 2020, overseeing a significant Horizon 2020 EU project focused on enzymatic polymer degradation. With a strong background in biocatalysis, Erik de Vries has held various advisory and consulting roles, including positions at Allozymes and FabricNano, and founded Industrial Biotechnology Consulting to assist startups in the biotechnology sector. Erik de Vries' prior experience includes roles in business development at Dottikon Exclusive Synthesis AG and regional sales management at Amyris Inc., complemented by a Doctorate in Bioorganic Chemistry from the University of Groningen.
This person is not in any offices
BRAIN Biotech AG
BRAIN Biotech AG is a leading European supplier of biobased products and solutions such as enzymes and proteins, microbial production strains, natural compounds and biotechnological solutions for more sustainable industrial processes. We focus on the fields of nutrition, health and environment. BRAIN Biotech AG is the parent company of the international BRAIN Biotech Group. The Group's business activities are divided into the segments BioProducts, BioScience and BioIncubator. The BioProducts segment comprises the product business with specialty enzymes and other proteins, for which the Group operates fermentation facilities in the United Kingdom and production facilities in continental Europe and the United States. The BioScience segment offers research-intensive custom solutions based on enzyme technology, strain development, bioprocess development and natural product screening. The BioIncubator segment conducts its own R&D projects or those initiated with partners with high value-added potential. A particularly promising incubator project is the development of the Company's own CRISPR-based gene editing technology platform, which is currently being established and expanded.